Global Brucellosis Vaccines Market ByType(RB-51, B19, S19, and Others);By Species (Brucella abortus, Brucella Melitensis, Brucella suis, Brucella ovis, and Others);By Application(Cattle and Pigs, Sheep, Goat, Dogs, and Others);By End-User (Hospitals and Clinics, Animal Care Centers, Research Centers, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia(Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia) Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of the Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Brucellosis is a livestock disease accountable for fetal loss due to miscarriages. Globally, this disease has a profound social and economic impact by reducing the ability of livestock producers to offer an adequate supply of disease-free dairy products and meat. Furthermore, to its presence in domesticated animals, brucellosis is harbored in many wildlife species creating new disease reservoirs, which tends to add difficulty in eradicating this disease. Therefore, broad and consistent use of the available vaccines would contribute to reducing the incidence of brucellosis. The key players operating in the global brucellosis vaccines market emphasize the launch of effective vaccines to help resolve this worldwide problem and increase their revenue. For instance, in October 2021, CZ VACCINES announced the launch of a new vaccine to their range of brucellosis vaccines, which is named B19 CZV Ocular. This new vaccine by ocular route provides active immunization of bovine brucellosis caused by B. abortus.
Moreover, the great advantage of this new vaccine is that the interference with the standard diagnostic tests is highly reduced since the serological response is of lower intensity and has a shorter duration when administered by the conjunctival route. The increasing spending on research and development of such innovative and effective products is likely to positively impact the global brucellosis vaccinesmarket growth in the forthcoming years. Presently, brucellosis vaccines available in the market cannot provide sterilizing immunity, and in certain conditions, vaccinated livestock is not protected against co-mingling brucella-infected wildlife. Given that these vaccines are insufficient in proving complete protection for some vaccinated livestock, alternatives are being sought, including genetic modifications of current vaccines or their reformulations.
The spread of brucellosis has not stopped during Covid-19. With the rising confirmed cases of brucellosis, the demand for its vaccine has also increased during a pandemic, which is a positive factor for thebrucellosis vaccines market. For instance, in November 2020, an outbreak of zoonotic diseases brucellosis spread across the coastal region of KwaZulu-Natal (a coastal South African Province), with initial confirmed cases totalling over 400 cows. However, several factors such as restrictions on transportation and raw material and a labor shortage are anticipated to negatively impact the market growth.
In terms of revenue, the global brucellosis vaccinesmarket was valued at US$ 267.2 Mn in 2021, growing at a CAGR of 4.65% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Brucellosis Vaccines Market Revenue & Forecast, (US$ Million), 2015 – 2030
Species Outlook
The global brucellosis vaccinesmarket has been segmented into brucella abortus, brucella melitensis, brucella suis, brucella ovis, and othersbased on the species. The Brucella abortus segment is likely to hold a considerable share in the global market. These vaccine play an essential role in bovine brucellosis control/eradication plans and has been effectively used worldwide for decades. RB51 and strain 19 are the approved Brucella abortus vaccines strains most commonly used to protect cattle against infection and abortion. Nevertheless, due to some drawbacks shown by these vaccines, the companies are putting much effort into the research and development of safer and more effective vaccines that could also be used in other susceptible species of animals.
ApplicationOutlook
Based on the application segment, the global brucellosis vaccines market has been segmented intocattle and pigs, sheep, goats, dogs, and others. In 2021, the cattle and pigs segment was likely to hold the major share of the global market. The increasing economic loss due to brucellosis spread among cattle’s and pigs, which is rising the demand for brucellosis vaccines from cattle and pigs producers. For instance, according to the data published by the National Centerof Biotechnology Information (NCBI), in India, Brucellosis in livestock is responsible for a total loss of USD 3.4 billion every year. The disease in buffalo and cattle accounted for approx. 95% of the total losses and it occurs due to brucellosis in livestock populations. The disease is accountable for a loss of USD 6.8 per cattle, USD18.2 per buffalo, and USD 0.6 per pig.
Region Outlook:
Asia Pacific region is anticipated to hold a significant share in the global brucellosis vaccines market. The increasing number of animals, especially cattle and buffalos, suffering from brucellosis is driving the demand for the product. Moreover, rising government spending on controlling/eliminating this disease is expected to positively impact the regional market growth. For instance, in 2019, the National Animal Disease Control Programme (NADCP) of India announced the launch of a new scheme for the control of Foot & Mouth Disease and Brucellosis by vaccinating 100% of sheep, goat, cattle, buffalo, and pig population for Foot & Mouth Disease and 100% bovine female calves of 8 months of age for brucellosis with the total amount of USD 1.75 billion for five years (2019-20 to 2023-24).
Competitive Landscape
The report provides both qualitative and quantitative research onthe globalbrucellosis vaccines market and provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. The report studies their global presence, competitors, service offerings and specification for each company, amongst others.
Some of the key players operating in the global brucellosis vaccines marketare:
- Ceva
- Colorado Serum Company
- Creative Biolabs
- C.Z. Veterinaria S.A.
- Fivet Animal Health
- Hester Biosciences Limited
- Indian Immunologicals Ltd.
- Jordan Bio-industries Center
- LABORATORIOS SYVA
- MSD Animal Health
- Sanvita Biotech
- Tecnovax
- veterinary technologies corporation
- Zoetis
- Other Market Participants
Global Brucellosis Vaccines Market
By Type
- RB-51
- B19
- S19
- Others
By Species
- Brucella abortus.
- Brucella Melitensis
- Brucella suis
- Brucella ovis
- Others
By Application
- Cattle and Pigs
- Sheep
- Goat
- Dogs
- Others
By End-User
- Hospitals and clinics
- Animal Care Centers
- Research Centers
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 – 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Brucellosis Vaccines Market
6. Market Synopsis: Brucellosis Vaccines Market
7. Brucellosis Vaccines Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Brucellosis Vaccines Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators: Brucellosis Vaccines Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Brucellosis Vaccines Market
8. Global Brucellosis Vaccines Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global Brucellosis Vaccines Market Revenue (US$ Mn)
8.2. Global Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. RB-51
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2021
8.2.1.3. Market Forecast, 2022 – 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 – 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 – 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 – 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 – 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 – 2030
8.2.2. B19
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 – 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 – 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 – 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 – 2030
8.2.3. S19
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2021
8.2.3.3. Market Forecast, 2022 – 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market Estimation, 2015 - 2021
8.2.3.5.1.2. Market Forecast, 2022 – 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2021
8.2.3.5.2.2. Market Forecast, 2022 – 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2021
8.2.3.5.3.2. Market Forecast, 2022 – 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2021
8.2.3.5.4.2. Market Forecast, 2022 – 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market Estimation, 2015 - 2021
8.2.3.5.5.2. Market Forecast, 2022 – 2030
8.2.4. Others
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2021
8.2.4.3. Market Forecast, 2022 – 2030
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market Estimation, 2015 - 2021
8.2.4.5.1.2. Market Forecast, 2022 – 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market Estimation, 2015 - 2021
8.2.4.5.2.2. Market Forecast, 2022 – 2030
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market Estimation, 2015 - 2021
8.2.4.5.3.2. Market Forecast, 2022 – 2030
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market Estimation, 2015 - 2021
8.2.4.5.4.2. Market Forecast, 2022 – 2030
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market Estimation, 2015 - 2021
8.2.4.5.5.2. Market Forecast, 2022 – 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9. Global Brucellosis Vaccines Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
9.2.1. Brucella abortus
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 – 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2. Brucella Melitensis
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 – 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 – 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 – 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 – 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 – 2030
9.2.3. Brucella suis
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2021
9.2.3.3. Market Forecast, 2022 – 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 – 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 – 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 – 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 – 2030
9.2.4. Brucella ovis
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2021
9.2.4.3. Market Forecast, 2022 – 2030
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market Estimation, 2015 - 2021
9.2.4.5.1.2. Market Forecast, 2022 – 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2021
9.2.4.5.2.2. Market Forecast, 2022 – 2030
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2021
9.2.4.5.3.2. Market Forecast, 2022 – 2030
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2021
9.2.4.5.4.2. Market Forecast, 2022 – 2030
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market Estimation, 2015 - 2021
9.2.4.5.5.2. Market Forecast, 2022 – 2030
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2021
9.2.5.3. Market Forecast, 2022 – 2030
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market Estimation, 2015 - 2021
9.2.5.5.1.2. Market Forecast, 2022 – 2030
9.2.5.5.2. Europe
9.2.5.5.2.1. Market Estimation, 2015 - 2021
9.2.5.5.2.2. Market Forecast, 2022 – 2030
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market Estimation, 2015 - 2021
9.2.5.5.3.2. Market Forecast, 2022 – 2030
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market Estimation, 2015 - 2021
9.2.5.5.4.2. Market Forecast, 2022 – 2030
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market Estimation, 2015 - 2021
9.2.5.5.5.2. Market Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Species
10. Global Brucellosis Vaccines Market Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Cattle and Pigs
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2021
10.2.1.3. Market Forecast, 2022 – 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Sheep
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.2.3. Goat
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2021
10.2.3.3. Market Forecast, 2022 – 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 – 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 – 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 – 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 – 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 – 2030
10.2.4. Dogs
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2021
10.2.4.3. Market Forecast, 2022 – 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 – 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 – 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 – 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 – 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 – 2030
10.2.5. Others
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2021
10.2.5.3. Market Forecast, 2022 – 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market Estimation, 2015 - 2021
10.2.5.5.1.2. Market Forecast, 2022 – 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2021
10.2.5.5.2.2. Market Forecast, 2022 – 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2021
10.2.5.5.3.2. Market Forecast, 2022 – 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2021
10.2.5.5.4.2. Market Forecast, 2022 – 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market Estimation, 2015 - 2021
10.2.5.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. Global Brucellosis Vaccines Market Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
11.2.1. Hospitals and clinics
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Animal Care Centers
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3. Research Centers
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2021
11.2.3.3. Market Forecast, 2022 – 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 – 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 – 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 – 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 – 2030
11.2.4. Others
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2021
11.2.4.3. Market Forecast, 2022 – 2030
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market Estimation, 2015 - 2021
11.2.4.5.1.2. Market Forecast, 2022 – 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2021
11.2.4.5.2.2. Market Forecast, 2022 – 2030
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2021
11.2.4.5.3.2. Market Forecast, 2022 – 2030
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2021
11.2.4.5.4.2. Market Forecast, 2022 – 2030
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market Estimation, 2015 - 2021
11.2.4.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End User
12. North America Brucellosis Vaccines Market Analysis and Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North America Brucellosis Vaccines Market Revenue (US$ Mn)
12.2. North America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
12.2.1. RB-51
12.2.2. B19
12.2.3. S19
12.2.4. Others
12.3. North America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
12.3.1. Brucella abortus
12.3.2. Brucella Melitensis
12.3.3. Brucella suis
12.3.4. Brucella ovis
12.3.5. Others
12.4. North America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
12.4.1. Cattle and Pigs
12.4.2. Sheep
12.4.3. Goat
12.4.4. Dogs
12.4.5. Others
12.5. North America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
12.5.1. Hospitals and clinics
12.5.2. Animal Care Centers
12.5.3. Research Centers
12.5.4. Others
12.6. North America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
12.6.1.1.1. RB-51
12.6.1.1.2. B19
12.6.1.1.3. S19
12.6.1.1.4. Others
12.6.1.2. U.S Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
12.6.1.2.1. Brucella abortus
12.6.1.2.2. Brucella Melitensis
12.6.1.2.3. Brucella suis
12.6.1.2.4. Brucella ovis
12.6.1.2.5. Others
12.6.1.3. U.S Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
12.6.1.3.1. Cattle and Pigs
12.6.1.3.2. Sheep
12.6.1.3.3. Goat
12.6.1.3.4. Dogs
12.6.1.3.5. Others
12.6.1.4. U.S Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
12.6.1.4.1. Hospitals and clinics
12.6.1.4.2. Animal Care Centers
12.6.1.4.3. Research Centers
12.6.1.4.4. Others
12.6.2. Canada
12.6.2.1. Canada Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
12.6.2.1.1. RB-51
12.6.2.1.2. B19
12.6.2.1.3. S19
12.6.2.1.4. Others
12.6.2.2. Canada Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
12.6.2.2.1. Brucella abortus
12.6.2.2.2. Brucella Melitensis
12.6.2.2.3. Brucella suis
12.6.2.2.4. Brucella ovis
12.6.2.2.5. Others
12.6.2.3. Canada Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
12.6.2.3.1. Cattle and Pigs
12.6.2.3.2. Sheep
12.6.2.3.3. Goat
12.6.2.3.4. Dogs
12.6.2.3.5. Others
12.6.2.4. Canada Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
12.6.2.4.1. Hospitals and clinics
12.6.2.4.2. Animal Care Centers
12.6.2.4.3. Research Centers
12.6.2.4.4. Others
12.6.3. Mexico
12.6.3.1. Mexico Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
12.6.3.1.1. RB-51
12.6.3.1.2. B19
12.6.3.1.3. S19
12.6.3.1.4. Others
12.6.3.2. Mexico Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
12.6.3.2.1. Brucella abortus
12.6.3.2.2. Brucella Melitensis
12.6.3.2.3. Brucella suis
12.6.3.2.4. Brucella ovis
12.6.3.2.5. Others
12.6.3.3. Mexico Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
12.6.3.3.1. Cattle and Pigs
12.6.3.3.2. Sheep
12.6.3.3.3. Goat
12.6.3.3.4. Dogs
12.6.3.3.5. Others
12.6.3.4. Mexico Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
12.6.3.4.1. Hospitals and clinics
12.6.3.4.2. Animal Care Centers
12.6.3.4.3. Research Centers
12.6.3.4.4. Others
12.6.4. Rest of North America
12.6.4.1. Rest of North America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
12.6.4.1.1. RB-51
12.6.4.1.2. B19
12.6.4.1.3. S19
12.6.4.1.4. Others
12.6.4.2. Rest of North America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
12.6.4.2.1. Brucella abortus
12.6.4.2.2. Brucella Melitensis
12.6.4.2.3. Brucella suis
12.6.4.2.4. Brucella ovis
12.6.4.2.5. Others
12.6.4.3. Rest of North America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
12.6.4.3.1. Cattle and Pigs
12.6.4.3.2. Sheep
12.6.4.3.3. Goat
12.6.4.3.4. Dogs
12.6.4.3.5. Others
12.6.4.4. Rest of North America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
12.6.4.4.1. Hospitals and clinics
12.6.4.4.2. Animal Care Centers
12.6.4.4.3. Research Centers
12.6.4.4.4. Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Type
12.7.3. By Species
12.7.4. By Application
12.7.5. By End User
13. Europe Brucellosis Vaccines Market Analysis and Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe Brucellosis Vaccines Market Revenue (US$ Mn)
13.2. Europe Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. RB-51
13.2.2. B19
13.2.3. S19
13.2.4. Others
13.3. Europe Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
13.3.1. Brucella abortus
13.3.2. Brucella Melitensis
13.3.3. Brucella suis
13.3.4. Brucella ovis
13.3.5. Others
13.4. Europe Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1. Cattle and Pigs
13.4.2. Sheep
13.4.3. Goat
13.4.4. Dogs
13.4.5. Others
13.5. Europe Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1. Hospitals and clinics
13.5.2. Animal Care Centers
13.5.3. Research Centers
13.5.4. Others
13.6. Europe Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
13.6.1.1.1. RB-51
13.6.1.1.2. B19
13.6.1.1.3. S19
13.6.1.1.4. Others
13.6.1.2. France Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
13.6.1.2.1. Brucella abortus
13.6.1.2.2. Brucella Melitensis
13.6.1.2.3. Brucella suis
13.6.1.2.4. Brucella ovis
13.6.1.2.5. Others
13.6.1.3. France Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.3.1. Cattle and Pigs
13.6.1.3.2. Sheep
13.6.1.3.3. Goat
13.6.1.3.4. Dogs
13.6.1.3.5. Others
13.6.1.4. France Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
13.6.1.4.1. Hospitals and clinics
13.6.1.4.2. Animal Care Centers
13.6.1.4.3. Research Centers
13.6.1.4.4. Others
13.6.2. The UK
13.6.2.1. The UK Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
13.6.2.1.1. RB-51
13.6.2.1.2. B19
13.6.2.1.3. S19
13.6.2.1.4. Others
13.6.2.2. The UK Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
13.6.2.2.1. Brucella abortus
13.6.2.2.2. Brucella Melitensis
13.6.2.2.3. Brucella suis
13.6.2.2.4. Brucella ovis
13.6.2.2.5. Others
13.6.2.3. The UK Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
13.6.2.3.1. Cattle and Pigs
13.6.2.3.2. Sheep
13.6.2.3.3. Goat
13.6.2.3.4. Dogs
13.6.2.3.5. Others
13.6.2.4. The UK Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
13.6.2.4.1. Hospitals and clinics
13.6.2.4.2. Animal Care Centers
13.6.2.4.3. Research Centers
13.6.2.4.4. Others
13.6.3. Spain
13.6.3.1. Spain Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
13.6.3.1.1. RB-51
13.6.3.1.2. B19
13.6.3.1.3. S19
13.6.3.1.4. Others
13.6.3.2. Spain Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
13.6.3.2.1. Brucella abortus
13.6.3.2.2. Brucella Melitensis
13.6.3.2.3. Brucella suis
13.6.3.2.4. Brucella ovis
13.6.3.2.5. Others
13.6.3.3. Spain Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
13.6.3.3.1. Cattle and Pigs
13.6.3.3.2. Sheep
13.6.3.3.3. Goat
13.6.3.3.4. Dogs
13.6.3.3.5. Others
13.6.3.4. Spain Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
13.6.3.4.1. Hospitals and clinics
13.6.3.4.2. Animal Care Centers
13.6.3.4.3. Research Centers
13.6.3.4.4. Others
13.6.4. Germany
13.6.4.1. Germany Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
13.6.4.1.1. RB-51
13.6.4.1.2. B19
13.6.4.1.3. S19
13.6.4.1.4. Others
13.6.4.2. Germany Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
13.6.4.2.1. Brucella abortus
13.6.4.2.2. Brucella Melitensis
13.6.4.2.3. Brucella suis
13.6.4.2.4. Brucella ovis
13.6.4.2.5. Others
13.6.4.3. Germany Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
13.6.4.3.1. Cattle and Pigs
13.6.4.3.2. Sheep
13.6.4.3.3. Goat
13.6.4.3.4. Dogs
13.6.4.3.5. Others
13.6.4.4. Germany Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
13.6.4.4.1. Hospitals and clinics
13.6.4.4.2. Animal Care Centers
13.6.4.4.3. Research Centers
13.6.4.4.4. Others
13.6.5. Italy
13.6.5.1. Italy Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
13.6.5.1.1. RB-51
13.6.5.1.2. B19
13.6.5.1.3. S19
13.6.5.1.4. Others
13.6.5.2. Italy Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
13.6.5.2.1. Brucella abortus
13.6.5.2.2. Brucella Melitensis
13.6.5.2.3. Brucella suis
13.6.5.2.4. Brucella ovis
13.6.5.2.5. Others
13.6.5.3. Italy Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
13.6.5.3.1. Cattle and Pigs
13.6.5.3.2. Sheep
13.6.5.3.3. Goat
13.6.5.3.4. Dogs
13.6.5.3.5. Others
13.6.5.4. Italy Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
13.6.5.4.1. Hospitals and clinics
13.6.5.4.2. Animal Care Centers
13.6.5.4.3. Research Centers
13.6.5.4.4. Others
13.6.6. Nordic Countries
13.6.6.1. Nordic Countries Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
13.6.6.1.1. RB-51
13.6.6.1.2. B19
13.6.6.1.3. S19
13.6.6.1.4. Others
13.6.6.2. Nordic Countries Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
13.6.6.2.1. Brucella abortus
13.6.6.2.2. Brucella Melitensis
13.6.6.2.3. Brucella suis
13.6.6.2.4. Brucella ovis
13.6.6.2.5. Others
13.6.6.3. Nordic Countries Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
13.6.6.3.1. Cattle and Pigs
13.6.6.3.2. Sheep
13.6.6.3.3. Goat
13.6.6.3.4. Dogs
13.6.6.3.5. Others
13.6.6.4. Nordic Countries Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
13.6.6.4.1. Hospitals and clinics
13.6.6.4.2. Animal Care Centers
13.6.6.4.3. Research Centers
13.6.6.4.4. Others
13.6.6.5. Nordic Countries Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux Union
13.6.7.1. Benelux Union Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
13.6.7.1.1. RB-51
13.6.7.1.2. B19
13.6.7.1.3. S19
13.6.7.1.4. Others
13.6.7.2. Benelux Union Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
13.6.7.2.1. Brucella abortus
13.6.7.2.2. Brucella Melitensis
13.6.7.2.3. Brucella suis
13.6.7.2.4. Brucella ovis
13.6.7.2.5. Others
13.6.7.3. Benelux Union Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
13.6.7.3.1. Cattle and Pigs
13.6.7.3.2. Sheep
13.6.7.3.3. Goat
13.6.7.3.4. Dogs
13.6.7.3.5. Others
13.6.7.4. Benelux Union Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
13.6.7.4.1. Hospitals and clinics
13.6.7.4.2. Animal Care Centers
13.6.7.4.3. Research Centers
13.6.7.4.4. Others
13.6.7.5. Benelux Union Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
13.6.8.1.1. RB-51
13.6.8.1.2. B19
13.6.8.1.3. S19
13.6.8.1.4. Others
13.6.8.2. Rest of Europe Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
13.6.8.2.1. Brucella abortus
13.6.8.2.2. Brucella Melitensis
13.6.8.2.3. Brucella suis
13.6.8.2.4. Brucella ovis
13.6.8.2.5. Others
13.6.8.3. Rest of Europe Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
13.6.8.3.1. Cattle and Pigs
13.6.8.3.2. Sheep
13.6.8.3.3. Goat
13.6.8.3.4. Dogs
13.6.8.3.5. Others
13.6.8.4. Rest of Europe Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
13.6.8.4.1. Hospitals and clinics
13.6.8.4.2. Animal Care Centers
13.6.8.4.3. Research Centers
13.6.8.4.4. Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Type
13.7.3. By Species
13.7.4. By Application
13.7.5. By End User
14. Asia Pacific Brucellosis Vaccines Market Analysis and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn)
14.2. Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. RB-51
14.2.2. B19
14.2.3. S19
14.2.4. Others
14.3. Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
14.3.1. Brucella abortus
14.3.2. Brucella Melitensis
14.3.3. Brucella suis
14.3.4. Brucella ovis
14.3.5. Others
14.4. Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Cattle and Pigs
14.4.2. Sheep
14.4.3. Goat
14.4.4. Dogs
14.4.5. Others
14.5. Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
14.5.1. Hospitals and clinics
14.5.2. Animal Care Centers
14.5.3. Research Centers
14.5.4. Others
14.6. Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
14.6.1.1.1. RB-51
14.6.1.1.2. B19
14.6.1.1.3. S19
14.6.1.1.4. Others
14.6.1.2. China Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
14.6.1.2.1. Brucella abortus
14.6.1.2.2. Brucella Melitensis
14.6.1.2.3. Brucella suis
14.6.1.2.4. Brucella ovis
14.6.1.2.5. Others
14.6.1.3. China Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1.3.1. Cattle and Pigs
14.6.1.3.2. Sheep
14.6.1.3.3. Goat
14.6.1.3.4. Dogs
14.6.1.3.5. Others
14.6.1.4. China Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
14.6.1.4.1. Hospitals and clinics
14.6.1.4.2. Animal Care Centers
14.6.1.4.3. Research Centers
14.6.1.4.4. Others
14.6.2. Japan
14.6.2.1. Japan Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
14.6.2.1.1. RB-51
14.6.2.1.2. B19
14.6.2.1.3. S19
14.6.2.1.4. Others
14.6.2.2. Japan Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
14.6.2.2.1. Brucella abortus
14.6.2.2.2. Brucella Melitensis
14.6.2.2.3. Brucella suis
14.6.2.2.4. Brucella ovis
14.6.2.2.5. Others
14.6.2.3. Japan Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
14.6.2.3.1. Cattle and Pigs
14.6.2.3.2. Sheep
14.6.2.3.3. Goat
14.6.2.3.4. Dogs
14.6.2.3.5. Others
14.6.2.4. Japan Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
14.6.2.4.1. Hospitals and clinics
14.6.2.4.2. Animal Care Centers
14.6.2.4.3. Research Centers
14.6.2.4.4. Others
14.6.3. India
14.6.3.1. India Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
14.6.3.1.1. RB-51
14.6.3.1.2. B19
14.6.3.1.3. S19
14.6.3.1.4. Others
14.6.3.2. India Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
14.6.3.2.1. Brucella abortus
14.6.3.2.2. Brucella Melitensis
14.6.3.2.3. Brucella suis
14.6.3.2.4. Brucella ovis
14.6.3.2.5. Others
14.6.3.3. India Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
14.6.3.3.1. Cattle and Pigs
14.6.3.3.2. Sheep
14.6.3.3.3. Goat
14.6.3.3.4. Dogs
14.6.3.3.5. Others
14.6.3.4. India Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
14.6.3.4.1. Hospitals and clinics
14.6.3.4.2. Animal Care Centers
14.6.3.4.3. Research Centers
14.6.3.4.4. Others
14.6.4. New Zealand
14.6.4.1. New Zealand Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
14.6.4.1.1. RB-51
14.6.4.1.2. B19
14.6.4.1.3. S19
14.6.4.1.4. Others
14.6.4.2. New Zealand Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
14.6.4.2.1. Brucella abortus
14.6.4.2.2. Brucella Melitensis
14.6.4.2.3. Brucella suis
14.6.4.2.4. Brucella ovis
14.6.4.2.5. Others
14.6.4.3. New Zealand Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
14.6.4.3.1. Cattle and Pigs
14.6.4.3.2. Sheep
14.6.4.3.3. Goat
14.6.4.3.4. Dogs
14.6.4.3.5. Others
14.6.4.4. New Zealand Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
14.6.4.4.1. Hospitals and clinics
14.6.4.4.2. Animal Care Centers
14.6.4.4.3. Research Centers
14.6.4.4.4. Others
14.6.5. Australia
14.6.5.1. Australia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
14.6.5.1.1. RB-51
14.6.5.1.2. B19
14.6.5.1.3. S19
14.6.5.1.4. Others
14.6.5.2. Australia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
14.6.5.2.1. Brucella abortus
14.6.5.2.2. Brucella Melitensis
14.6.5.2.3. Brucella suis
14.6.5.2.4. Brucella ovis
14.6.5.2.5. Others
14.6.5.3. Australia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
14.6.5.3.1. Cattle and Pigs
14.6.5.3.2. Sheep
14.6.5.3.3. Goat
14.6.5.3.4. Dogs
14.6.5.3.5. Others
14.6.5.4. Australia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
14.6.5.4.1. Hospitals and clinics
14.6.5.4.2. Animal Care Centers
14.6.5.4.3. Research Centers
14.6.5.4.4. Others
14.6.6. South Korea
14.6.6.1. South Korea Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
14.6.6.1.1. RB-51
14.6.6.1.2. B19
14.6.6.1.3. S19
14.6.6.1.4. Others
14.6.6.2. South Korea Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
14.6.6.2.1. Brucella abortus
14.6.6.2.2. Brucella Melitensis
14.6.6.2.3. Brucella suis
14.6.6.2.4. Brucella ovis
14.6.6.2.5. Others
14.6.6.3. South Korea Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
14.6.6.3.1. Cattle and Pigs
14.6.6.3.2. Sheep
14.6.6.3.3. Goat
14.6.6.3.4. Dogs
14.6.6.3.5. Others
14.6.6.4. South Korea Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
14.6.6.4.1. Hospitals and clinics
14.6.6.4.2. Animal Care Centers
14.6.6.4.3. Research Centers
14.6.6.4.4. Others
14.6.7. Southeast Asia
14.6.7.1. Southeast Asia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
14.6.7.1.1. RB-51
14.6.7.1.2. B19
14.6.7.1.3. S19
14.6.7.1.4. Others
14.6.7.2. Southeast Asia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
14.6.7.2.1. Brucella abortus
14.6.7.2.2. Brucella Melitensis
14.6.7.2.3. Brucella suis
14.6.7.2.4. Brucella ovis
14.6.7.2.5. Others
14.6.7.3. Southeast Asia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
14.6.7.3.1. Cattle and Pigs
14.6.7.3.2. Sheep
14.6.7.3.3. Goat
14.6.7.3.4. Dogs
14.6.7.3.5. Others
14.6.7.4. Southeast Asia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
14.6.7.4.1. Hospitals and clinics
14.6.7.4.2. Animal Care Centers
14.6.7.4.3. Research Centers
14.6.7.4.4. Others
14.6.7.5. Southeast Asia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1. Rest of Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
14.6.8.1.1. RB-51
14.6.8.1.2. B19
14.6.8.1.3. S19
14.6.8.1.4. Others
14.6.8.2. Rest of Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
14.6.8.2.1. Brucella abortus
14.6.8.2.2. Brucella Melitensis
14.6.8.2.3. Brucella suis
14.6.8.2.4. Brucella ovis
14.6.8.2.5. Others
14.6.8.3. Rest of Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
14.6.8.3.1. Cattle and Pigs
14.6.8.3.2. Sheep
14.6.8.3.3. Goat
14.6.8.3.4. Dogs
14.6.8.3.5. Others
14.6.8.4. Rest of Asia Pacific Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
14.6.8.4.1. Hospitals and clinics
14.6.8.4.2. Animal Care Centers
14.6.8.4.3. Research Centers
14.6.8.4.4. Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Type
14.7.3. By Species
14.7.4. By Application
14.7.5. By End User
15. Middle East and Africa Brucellosis Vaccines Market Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle East and Africa Brucellosis Vaccines Market Revenue (US$ Mn)
15.2. Middle East and Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
15.2.1. RB-51
15.2.2. B19
15.2.3. S19
15.2.4. Others
15.3. Middle East and Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
15.3.1. Brucella abortus
15.3.2. Brucella Melitensis
15.3.3. Brucella suis
15.3.4. Brucella ovis
15.3.5. Others
15.4. Middle East and Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Cattle and Pigs
15.4.2. Sheep
15.4.3. Goat
15.4.4. Dogs
15.4.5. Others
15.5. Middle East and Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
15.5.1. Hospitals and clinics
15.5.2. Animal Care Centers
15.5.3. Research Centers
15.5.4. Others
15.6. Middle East and Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1. Saudi Arabia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
15.6.1.1.1. RB-51
15.6.1.1.2. B19
15.6.1.1.3. S19
15.6.1.1.4. Others
15.6.1.2. Saudi Arabia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
15.6.1.2.1. Brucella abortus
15.6.1.2.2. Brucella Melitensis
15.6.1.2.3. Brucella suis
15.6.1.2.4. Brucella ovis
15.6.1.2.5. Others
15.6.1.3. Saudi Arabia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1.3.1. Cattle and Pigs
15.6.1.3.2. Sheep
15.6.1.3.3. Goat
15.6.1.3.4. Dogs
15.6.1.3.5. Others
15.6.1.4. Saudi Arabia Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
15.6.1.4.1. Hospitals and clinics
15.6.1.4.2. Animal Care Centers
15.6.1.4.3. Research Centers
15.6.1.4.4. Others
15.6.2. UAE
15.6.2.1. UAE Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
15.6.2.1.1. RB-51
15.6.2.1.2. B19
15.6.2.1.3. S19
15.6.2.1.4. Others
15.6.2.2. UAE Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
15.6.2.2.1. Brucella abortus
15.6.2.2.2. Brucella Melitensis
15.6.2.2.3. Brucella suis
15.6.2.2.4. Brucella ovis
15.6.2.2.5. Others
15.6.2.3. UAE Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
15.6.2.3.1. Cattle and Pigs
15.6.2.3.2. Sheep
15.6.2.3.3. Goat
15.6.2.3.4. Dogs
15.6.2.3.5. Others
15.6.2.4. UAE Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
15.6.2.4.1. Hospitals and clinics
15.6.2.4.2. Animal Care Centers
15.6.2.4.3. Research Centers
15.6.2.4.4. Others
15.6.3. Egypt
15.6.3.1. Egypt Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
15.6.3.1.1. RB-51
15.6.3.1.2. B19
15.6.3.1.3. S19
15.6.3.1.4. Others
15.6.3.2. Egypt Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
15.6.3.2.1. Brucella abortus
15.6.3.2.2. Brucella Melitensis
15.6.3.2.3. Brucella suis
15.6.3.2.4. Brucella ovis
15.6.3.2.5. Others
15.6.3.3. Egypt Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
15.6.3.3.1. Cattle and Pigs
15.6.3.3.2. Sheep
15.6.3.3.3. Goat
15.6.3.3.4. Dogs
15.6.3.3.5. Others
15.6.3.4. Egypt Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
15.6.3.4.1. Hospitals and clinics
15.6.3.4.2. Animal Care Centers
15.6.3.4.3. Research Centers
15.6.3.4.4. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
15.6.4.1.1. RB-51
15.6.4.1.2. B19
15.6.4.1.3. S19
15.6.4.1.4. Others
15.6.4.2. Kuwait Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
15.6.4.2.1. Brucella abortus
15.6.4.2.2. Brucella Melitensis
15.6.4.2.3. Brucella suis
15.6.4.2.4. Brucella ovis
15.6.4.2.5. Others
15.6.4.3. Kuwait Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
15.6.4.3.1. Cattle and Pigs
15.6.4.3.2. Sheep
15.6.4.3.3. Goat
15.6.4.3.4. Dogs
15.6.4.3.5. Others
15.6.4.4. Kuwait Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
15.6.4.4.1. Hospitals and clinics
15.6.4.4.2. Animal Care Centers
15.6.4.4.3. Research Centers
15.6.4.4.4. Others
15.6.5. South Africa
15.6.5.1. South Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
15.6.5.1.1. RB-51
15.6.5.1.2. B19
15.6.5.1.3. S19
15.6.5.1.4. Others
15.6.5.2. South Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
15.6.5.2.1. Brucella abortus
15.6.5.2.2. Brucella Melitensis
15.6.5.2.3. Brucella suis
15.6.5.2.4. Brucella ovis
15.6.5.2.5. Others
15.6.5.3. South Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
15.6.5.3.1. Cattle and Pigs
15.6.5.3.2. Sheep
15.6.5.3.3. Goat
15.6.5.3.4. Dogs
15.6.5.3.5. Others
15.6.5.4. South Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
15.6.5.4.1. Hospitals and clinics
15.6.5.4.2. Animal Care Centers
15.6.5.4.3. Research Centers
15.6.5.4.4. Others
15.6.6. Rest of Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
15.6.6.1.1. RB-51
15.6.6.1.2. B19
15.6.6.1.3. S19
15.6.6.1.4. Others
15.6.6.2. Rest of Middle East & Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
15.6.6.2.1. Brucella abortus
15.6.6.2.2. Brucella Melitensis
15.6.6.2.3. Brucella suis
15.6.6.2.4. Brucella ovis
15.6.6.2.5. Others
15.6.6.3. Rest of Middle East & Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1. Cattle and Pigs
15.6.6.3.2. Sheep
15.6.6.3.3. Goat
15.6.6.3.4. Dogs
15.6.6.3.5. Others
15.6.6.4. Rest of Middle East & Africa Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
15.6.6.4.1. Hospitals and clinics
15.6.6.4.2. Animal Care Centers
15.6.6.4.3. Research Centers
15.6.6.4.4. Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Type
15.7.3. By Species
15.7.4. By Application
15.7.5. By End User
16. Latin America Brucellosis Vaccines Market Analysis and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin America Brucellosis Vaccines Market Revenue (US$ Mn)
16.2. Latin America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
16.2.1. RB-51
16.2.2. B19
16.2.3. S19
16.2.4. Others
16.3. Latin America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
16.3.1. Brucella abortus
16.3.2. Brucella Melitensis
16.3.3. Brucella suis
16.3.4. Brucella ovis
16.3.5. Others
16.4. Latin America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
16.4.1. Cattle and Pigs
16.4.2. Sheep
16.4.3. Goat
16.4.4. Dogs
16.4.5. Others
16.5. Latin America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
16.5.1. Hospitals and clinics
16.5.2. Animal Care Centers
16.5.3. Research Centers
16.5.4. Others
16.6. Latin America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
16.6.1.1.1. RB-51
16.6.1.1.2. B19
16.6.1.1.3. S19
16.6.1.1.4. Others
16.6.1.2. Brazil Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
16.6.1.2.1. Brucella abortus
16.6.1.2.2. Brucella Melitensis
16.6.1.2.3. Brucella suis
16.6.1.2.4. Brucella ovis
16.6.1.2.5. Others
16.6.1.3. Brazil Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.3.1. Cattle and Pigs
16.6.1.3.2. Sheep
16.6.1.3.3. Goat
16.6.1.3.4. Dogs
16.6.1.3.5. Others
16.6.1.4. Brazil Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
16.6.1.4.1. Hospitals and clinics
16.6.1.4.2. Animal Care Centers
16.6.1.4.3. Research Centers
16.6.1.4.4. Others
16.6.2. Argentina
16.6.2.1. Argentina Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
16.6.2.1.1. RB-51
16.6.2.1.2. B19
16.6.2.1.3. S19
16.6.2.1.4. Others
16.6.2.2. Argentina Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
16.6.2.2.1. Brucella abortus
16.6.2.2.2. Brucella Melitensis
16.6.2.2.3. Brucella suis
16.6.2.2.4. Brucella ovis
16.6.2.2.5. Others
16.6.2.3. Argentina Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
16.6.2.3.1. Cattle and Pigs
16.6.2.3.2. Sheep
16.6.2.3.3. Goat
16.6.2.3.4. Dogs
16.6.2.3.5. Others
16.6.2.4. Argentina Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
16.6.2.4.1. Hospitals and clinics
16.6.2.4.2. Animal Care Centers
16.6.2.4.3. Research Centers
16.6.2.4.4. Others
16.6.3. Rest of Latin America
16.6.3.1. Rest of Latin America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Type
16.6.3.1.1. RB-51
16.6.3.1.2. B19
16.6.3.1.3. S19
16.6.3.1.4. Others
16.6.3.2. Rest of Latin America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Species
16.6.3.2.1. Brucella abortus
16.6.3.2.2. Brucella Melitensis
16.6.3.2.3. Brucella suis
16.6.3.2.4. Brucella ovis
16.6.3.2.5. Others
16.6.3.3. Rest of Latin America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By Application
16.6.3.3.1. Cattle and Pigs
16.6.3.3.2. Sheep
16.6.3.3.3. Goat
16.6.3.3.4. Dogs
16.6.3.3.5. Others
16.6.3.4. Rest of Latin America Brucellosis Vaccines Market Revenue (US$ Mn) and Forecasts, By End User
16.6.3.4.1. Hospitals and clinics
16.6.3.4.2. Animal Care Centers
16.6.3.4.3. Research Centers
16.6.3.4.4. Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Type
16.7.3. By Species
16.7.4. By Application
16.7.5. By End User
17. Competitive Benchmarking
17.1. Market Share Analysis, 2021
17.2. Global Presence and Growth Strategies
17.2.1. Mergers and Acquisitions
17.2.2. Product Launches
17.2.3. Investments Trends
17.2.4. R&D Initiatives
18. Player Profiles
18.1. Ceva
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Colorado Serum Company
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Creative Biolabs
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. CZ Veterinaria S.A.
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. Fivet Animal Health
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Hester Biosciences Limited
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. Indian Immunologicals Ltd.
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Jordan Bio-industries Center
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. LABORATORIOS SYVA
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. MSD Animal Health
18.10.1. Company Details
18.10.2. Company Overview
18.10.3. Product Offerings
18.10.4. Key Developments
18.10.5. Financial Analysis
18.10.6. SWOT Analysis
18.10.7. Business Strategies
18.11. Sanvita Biotech
18.11.1. Company Details
18.11.2. Company Overview
18.11.3. Product Offerings
18.11.4. Key Developments
18.11.5. Financial Analysis
18.11.6. SWOT Analysis
18.11.7. Business Strategies
18.12. Tecnovax
18.12.1. Company Details
18.12.2. Company Overview
18.12.3. Product Offerings
18.12.4. Key Developments
18.12.5. Financial Analysis
18.12.6. SWOT Analysis
18.12.7. Business Strategies
18.13. veterinary technologies corporation
18.13.1. Company Details
18.13.2. Company Overview
18.13.3. Product Offerings
18.13.4. Key Developments
18.13.5. Financial Analysis
18.13.6. SWOT Analysis
18.13.7. Business Strategies
18.14. Zoetis
18.14.1. Company Details
18.14.2. Company Overview
18.14.3. Product Offerings
18.14.4. Key Developments
18.14.5. Financial Analysis
18.14.6. SWOT Analysis
18.14.7. Business Strategies
18.15. Other market participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
